We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Manual Therapy Treatment for Myofascial Pain

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01381380
First Posted: June 27, 2011
Last Update Posted: June 27, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Federal University of São Paulo
  Purpose
This study is a pain intensity evaluation in patients with myofascial pain submitted kinesitherapy after trigger point injection.

Condition Intervention
Myofascial Pain Syndromes Procedure: Manual therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effect of Manual Therapy After Trigger Point Injection for Myofascial Pain Syndrome

Resource links provided by NLM:


Further study details as provided by Federal University of São Paulo:

Primary Outcome Measures:
  • Pain intensity [ Time Frame: 8 weeks ]
    once a week for 8 weeks (T1 to T8)


Enrollment: 30
Study Start Date: November 2006
Study Completion Date: December 2009
Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
single-arm studies
Manual therapy for one group
Procedure: Manual therapy
Manual therapy, once a week for 8 weeks
Other Names:
  • massage
  • finger pressure
  • myofascial release
  • mobilization

Detailed Description:

Randomized prospective study conducted on 30 patients of both genders ranging in age from 18 to 60 years, with neck and shoulder girdle Myofascial Pain Syndrome (MFS), with a duration of ≥ 4 months and pain intensity ≥ 4.

Trigger point injection of 1 mL 0.25% bupivacaine at each point, once a week for 8 weeks (T1 to T8).

Group 1: kinesiotherapy once a week for 8 weeks Group 2: not submitted to kinesiotherapy Evaluation of pain intensity on the first assessment (T0) and after 1, 2, 3, 4, 5, 6, 7, 8, and 9 weeks

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • myofascial pain of neck and shoulder girdle, lasting ≥ 4 months, pain intensity ≥ 4.

Exclusion Criteria:

  • arrhythmia
  • heart block
  • coagulopathy
  • cognitive alterations and infection at the site
  • patients using anticoagulants, and pregnant women
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01381380


Locations
Brazil
Setor de Dor
São Paulo, Brazil, 04023-062
Sponsors and Collaborators
Federal University of São Paulo
Investigators
Study Director: Rioko K Sakata, PhD Universidade Federal de São Paulo
  More Information

Responsible Party: Rioko Kimiko Sakata, Universidade Federal de São Paulo
ClinicalTrials.gov Identifier: NCT01381380     History of Changes
Other Study ID Numbers: 1276
First Submitted: June 23, 2011
First Posted: June 27, 2011
Last Update Posted: June 27, 2011
Last Verified: November 2007

Keywords provided by Federal University of São Paulo:
myofascial pain
trigger point injection
manual therapy

Additional relevant MeSH terms:
Syndrome
Myofascial Pain Syndromes
Fibromyalgia
Disease
Pathologic Processes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases